Home | Welcome to Contract Pharma   
Last Updated Saturday, November 29 2014
Print

Search Results for 'Phase II'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Quarterly Survey On CRO’s and CMO’s
Published April 22, 2014
During the fourth quarter of 2013, small-to-midsize clients drove contract pharma business Read More »
By Gil Roth
Published November 5, 2013
End-of-Phase II meeting with FDA goes well Read More »
By Gil Roth
Published October 15, 2013
Phase II data form EMA application of ovarian cancer treatment Read More »
By Gil Roth
Published October 15, 2013
Hopes to begin Phase III trials in 2014 Read More »
Western Eastern Europe
By Tomas Novak, Maxim Belotserkovsky, Veronika Fekete and Katarzyna Moscicka, PSI
Published October 9, 2013
Another region on a global map of international clinical trials Read More »
Published August 5, 2013
Anderson, Birkhofer, and Shimota join leadership team Read More »
Published March 6, 2013
Aims to advance Quarfloxin and associated anticancer technologies Read More »
The Struggle with Clinical Study Budgeting
By Andrew Grygiel
Published October 11, 2011
Industry survey reports problems with accuracy and efficiency Read More »
Published August 30, 2011
Partnership covers clinical pharmacology and exploratory clinical studies Read More »
Published May 10, 2006
Kendle will acquire the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. for approximately $215 million in cash. The move will strengthen Kendle's position in the clinical development industry, adding therapeut… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On